Oral vac­cine play­er lays off 27% of staff as it shelves Covid work

Af­ter spend­ing much of the past few years tout­ing its ex­per­i­men­tal Covid-19 vac­cine pill, Vaxart is pulling back and shelv­ing all fur­ther tri­als.

It has …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.